跳至主要内容
临床试验/IRCT20131013014994N7
IRCT20131013014994N7尚未招募3 期

The effect of synbiotic supplementation on plasma levels of Advanced Glycation End Products and cardiovascular risk factors in hemodialysis patients: a double-blind clinical trial

Kermanshah University of Medical Sciences0 个研究点目标入组 34 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
34

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Perform HD treatment at least twice a week for a maximum of 4 hours each time
  • Treatment under HD for at least 6 months
  • No pregnancy or breastfeeding
  • No immune system defects
  • No history of active cancers
  • No history of severe chronic diseases and acute medical conditions such as lung disease, cardiovascular disease, liver disease and acute pancreatitis
  • No addiction to alcohol or drugs
  • Lack of severe digestive disorders and diseases, HIV disease, mental problems
  • Ability to drink at least 200 ml of water per day
  • Life expectancy and survival for at least 3 months
  • Confirmation of written consent

排除标准

  • Patients with severe edema
  • People who had infection 4 weeks ago
  • People who took synbiotics, probiotics, prebiotics, or antibiotics during the 4 weeks before the study
  • Candidates for kidney and organ transplantation or peritoneal dialysis during 3 months of study
  • Taking immunosuppressive drugs or anticoagulants and chemotherapy drugs
  • Sensitivity to complementary compounds
  • The patient's unwillingness to participate in the study
  • Lack of complete answers to questions
  • Report side effects from taking synbiotics

研究者

相似试验